Seromic profiling of ovarian and pancreatic cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 11, 2010, Pages 5088-5093

  Gnjatic, Sacha ^a   Ritter, Erika ^a   Büchler, Markus W ^b   Giese, Nathalia A ^b   Brors, Benedikt ^b   Frei, Claudia ^b   Murray, Anne ^a   Halama, Niels ^b   Zörnig, Inka ^b   Chen, Yao Tseng ^c   Andrews, Christopher ^d   Ritter, Gerd ^a   Old, Lloyd J ^a   Odunsi, Kunle ^d   Jäger, Dirk ^b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Autoantigen; Biomarkers; Protein microarrays; Serology; Serum antibody

Indexed keywords

ANTIGEN; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIGEN BINDING; ARTICLE; CANCER IMMUNOLOGY; CANCER PATIENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN MICROARRAY; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SEROLOGY; SERUM; SIGNAL DETECTION; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOOD DONORS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, NEOPLASM; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOME; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950441069     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914213107     Document Type: Article

References (37)

1. Quintana FJ, et al. (2008) Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci USA 105:18889-18894.
2. Babel I, et al. (2009) Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 8: 2382-2395.
3. Belousov PV, et al. (2008) Cancer-associated antigens and antigen arrays in serological diagnostics of malignant tumors. Biochemistry (Mosc) 73:562-572.
4. Kijanka G, Murphy D (2009) Protein arrays as tools for serum autoantibody marker discovery in cancer. J Proteomics 72:936-944.
5. Chatterjee M, Wojciechowski J, Tainsky MA (2009) Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput. Methods Mol Biol 520:21-38.
6. Tan EM, Zhang J (2008) Autoantibodies to tumor-associated antigens: Reporters from the immune system. Immunol Rev 222:328-340.
7. Canzler U, et al. (2009) Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot array. Scand J Immunol 69:563-569.
8. Hueber W, et al. (2005) Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 52:2645-2655. (Pubitemid 41369092)
9. Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M (2007) Identification of differentially expressed proteins in ovarian cancer using high-density proteinmicroarrays. Proc Natl Acad Sci USA 104:17494-17499. (Pubitemid 350219866)
10. Madi A, et al. (2009) Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data. Proc Natl Acad Sci USA 106:14484-14489.
11. Taylor DD, Gercel-Taylor C, Parker LP (2009) Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol 115:112-120.
12. Chatterjee M, et al. (2006) Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 66:1181-1190. (Pubitemid 43165989)
13. Anderson KS, et al. (2008) Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 7:1490-1499.
14. Hong SH, et al. (2004) An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Res 64:5504-5510.
15. Chen G, et al. (2007) Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 67:3461-3467. (Pubitemid 46724887)
16. Albertus DL, et al. (2008) AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. J Thorac Oncol 3: 1236-1244.
17. Li B, et al. (2005) Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Infect Immun 73:3734-3739. (Pubitemid 40745918)
18. Davies DH, et al. (2007) Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7:1678-1686.
19. Gnjatic S, Old LJ, Chen YT (2009) Autoantibodies against cancer antigens. Methods in Molecular Biology, ed Tainsky MA (Humana, Totowa, NJ), Vol Vol 520, pp 11-19.
20. Gnjatic S, et al. (2009) Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. J Immunol Methods 341:50-58.
21. Michaud GA, et al. (2003) Analyzing antibody specificity with whole proteome microarrays. Nat Biotechnol 21:1509-1512.
22. Odunsi K, et al. (2003) NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Res 63:6076-6083. (Pubitemid 37187513)
23. Yakirevich E, et al. (2003) Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Clin Cancer Res 9:6453-6460. (Pubitemid 38031833)
24. Tammela J, et al. (2006) OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer. Int J Oncol 29:903-910.
25. Wadle A, et al. (2006) Serological immune response to cancer testis antigens in patients with pancreatic cancer. Int J Cancer 119:117-125.
26. Schmitz-Winnenthal FH, et al. (2007) Potential target antigens for immunotherapy in human pancreatic cancer. Cancer Lett 252:290-298.
27. Chen Y-T (2004) Identification of human tumor antigens by serological expression cloning: An online review on SEREX. Cancer Immun Available at http://www.cancerimmunity.org/SEREX.
28. Philip R, et al. (2007) Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: Potential theranostic approach to cancer. J Proteome Res 6:2509-2517. (Pubitemid 47122348)
29. Patwa TH, et al. (2009) The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray. Electrophoresis 30:2215-2226.
30. Ehmann M, et al. (2007) Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 34:205-214. (Pubitemid 46294796)
31. Gnjatic S, et al. (2006) NY-ESO-1: Review of an immunogenic tumor antigen. Adv Cancer Res 95:1-30. (Pubitemid 44088423)
32. Reuschenbach M, von Knebel Doeberitz M, Wentzensen N (2009) A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother 58:1535-1544.
33. Soussi T (2000) p53 antibodies in the sera of patients with various types of cancer: A review. Cancer Res 60:1777-1788. (Pubitemid 30207629)
34. Gaiger A, et al. (2001) WT1-specific serum antibodies in patients with leukemia. Clin Cancer Res 7 (Suppl 3):761s-765s.
35. Bergqvist M, et al. (2003) The presence of anti-p53 antibodies in sera prior to thoracic surgery in non small cell lung cancer patients: Its implications on tumor volume, nodal involvement, and survival. Neoplasia 5:283-287. (Pubitemid 37048605)
36. Nakagawa K, et al. (2005) XAGE-1 expression in non-small cell lung cancer and antibody response in patients. Clin Cancer Res 11:5496-5503. (Pubitemid 41060826)
37. Mitsudomi T, et al. (1998) Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. J Natl Cancer Inst 90:1563-1568. (Pubitemid 28535722)